Search results for Infinity

Nudge.ai was a relationship intelligence platform designed to help sales and customer success teams build and strengthen professional relationships. By leveraging artificial intelligence, Nudge.ai provided actionable insights into buyer activities, enabling sales professionals to engage more effectively and authentically with their prospects. The platform integrated seamlessly with tools like Gmail, Outlook, Salesforce, SalesLoft, and Outreach, ensuring minimal setup and a smooth user experience. Key Features and Functionality: - Automated Relationship Insights: Nudge.ai utilized AI to monitor and analyze buyer activities, delivering timely alerts and updates about prospects' company news, social media activity, and other relevant events. - Seamless Integration: The platform integrated with existing sales tools, including Gmail, Outlook, Salesforce, SalesLoft, and Outreach, allowing users to access insights directly within their preferred applications. - Intelligent Follow-Up Cadences: Nudge.ai enabled sales teams to set intelligent follow-up schedules based on relationship strength, ensuring timely and personalized outreach. - Smart Templates: The platform offered customizable templates that allowed for instant personalization of email communications, enhancing engagement and response rates. Primary Value and User Solutions: Nudge.ai addressed the challenge of maintaining and nurturing professional relationships in the sales process. By automating the research and monitoring of prospects' activities, it freed sales professionals from time-consuming tasks, allowing them to focus on meaningful interactions. The platform's insights enabled users to engage with prospects at the right time with relevant information, leading to more authentic conversations and improved sales outcomes. Ultimately, Nudge.ai aimed to humanize sales engagement by providing the tools necessary to build and sustain strong business relationships. Please note that as of January 2020, Nudge.ai ceased operations and its assets were acquired by Affinity, a San Francisco-based company.

PipeBio is a cloud-based bioinformatics platform designed to streamline the discovery and development of biologics, including antibodies, T-cell receptors (TCRs), and peptides. It offers scientists and bioinformaticians a comprehensive suite of tools for analyzing, visualizing, and managing large-scale sequence data, facilitating faster and more efficient research processes. Key Features and Functionality: - Sequence Analysis: Supports the analysis of B-cell receptors (BCR), TCRs, single-chain variable fragments (scFv), variable heavy domains (VHH), and peptides, enabling detailed examination and annotation of sequences. - Automated Workflows: Allows users to configure and execute end-to-end workflows, automating the identification of candidate sequences from extensive next-generation sequencing (NGS) antibody repertoires, hybridoma sequencing, and biopanning experiments. - Sequence Database and Storage: Provides a centralized database to store antibody sequences, associate relevant metadata such as target specificity and binding affinity, and compare new experimental sequences with existing data. - Integration and API: Offers integration capabilities with electronic lab notebooks (ELN), laboratory information management systems (LIMS), and internal tools through a REST API, facilitating seamless data exchange and workflow automation. - Visualization Tools: Includes interactive charts and plots to visualize sequence clusters, amino acid frequencies, codon usage, sequence quality, and phylogenetic relationships, enhancing data interpretation. - Antibody Engineering: Features tools for editing sequences at the nucleotide or protein level, calculating protein properties, optimizing codons for synthesis, and analyzing hydrophobicity, supporting the engineering of improved antibody candidates. Primary Value and Problem Solved: PipeBio addresses the challenges associated with managing and analyzing large-scale sequence data in biologics research. By providing an integrated, user-friendly platform, it enables researchers to efficiently process and interpret complex datasets, identify promising candidates, and accelerate the development of therapeutic biologics. The platform's automation and integration capabilities reduce manual tasks, minimize errors, and enhance collaboration, ultimately leading to faster and more effective drug discovery processes.

Eliminate timecards and timesheets

ICON is a creative agency with national, international and multicultural experience in CPG and beyond. Our expertise includes creating packaging, digital and experiential campaigns for growing challenger brands and multinational corporations expanding into new markets. Services include: Packaging – Standouts come in big and small packages. Nothing engages customers in the aisle like great packaging. Our mission is always to set product apart on shelf – so more of it moves off the shelf. Point of Sale – There’s no better place to make a big statement. Whether we’re creating a small end cap or a large freestanding display, we make sure customers can’t resist reaching out for what’s inside. Marketing Communications – Good communication comes in all sizes. From simple sales sheets to complex motivational campaigns, we find the right words to reach every reader and the images that speak volumes. Brand Innovation – Big ideas lead to monumental results. Our idea factory is always running. From strategizing to concepting, we’re always figuring out new ways to see things and do things. Experiential Events – Winning hearts and minds with events of any size. We’ve run corporate events, retail experiences and thought-leading talks. Across them all, one thing remains consistent: give people a good experience, and your relationship with them will last well beyond it. Digital – A bit of new content can build a larger audience. For both leading legacy brands and small independent ones, digital and social are now the first arena for building brand affinity. We deliver the right mix of content and responsive design to bring your story to your fans and keep them following along. Big ideas start with the small details. At ICON, we don’t just make your brand pretty. We take the time to get to know it. Simply put, we do whatever it takes to deliver world-class creative solutions that work for you.

eBrief Ready is an advanced electronic briefing platform designed to streamline document management and collaboration for legal professionals. It offers a secure, centralized environment where barristers, solicitors, and courts can efficiently share, review, and reference case materials throughout the lifecycle of a legal matter. By transitioning from traditional, manual processes to a digital solution, eBrief Ready enhances productivity and ensures seamless communication among all parties involved. Key Features and Functionality: - Digital Brief Sharing: Instantly share briefs without the need for large email attachments, ensuring quick and secure distribution of documents. - Real-Time Collaboration: Facilitate simultaneous access and editing of documents by solicitors, barristers, expert witnesses, and internal teams, regardless of location. - Automated Court Book Compilation: Automatically compile, index, and paginate court books, presenting them in a professional and court-friendly format. - Advanced Search Capabilities: Utilize Optical Character Recognition (OCR technology to quickly search through extensive documents, enhancing information retrieval. - Third-Party Integrations: Seamlessly integrate with widely used legal software such as iManage, Smokeball, Actionstep, Lexis Affinity, EvolveGo, and FilePro, allowing firms to incorporate eBrief Ready into their existing technology stack. - Multimedia Support: Upload various file types, including video, audio, images, emails, and Office documents, with automatic conversion to PDF format and instant media previews. Primary Value and User Solutions: eBrief Ready addresses the inefficiencies inherent in traditional brief management by providing a digital solution that enhances collaboration, reduces manual workload, and improves document accessibility. Legal professionals benefit from a more organized and efficient workflow, leading to better case preparation and presentation. The platform's secure environment ensures the confidentiality of sensitive information, while its integration capabilities allow for a cohesive technology ecosystem within law firms. By adopting eBrief Ready, legal practitioners can focus more on their core responsibilities, confident that their document management processes are optimized and reliable.

Convexia is an AI-driven platform designed to revolutionize drug discovery by accelerating the identification and evaluation of overlooked drug assets. By integrating advanced artificial intelligence with expert human review, Convexia streamlines the traditionally lengthy and fragmented drug development process, enabling faster and more efficient progression from asset discovery to clinical trials. Key Features and Functionality: 1. Asset Discovery Agent: Scans global data to identify high-potential drug assets, including preclinical biotech developments and abandoned pharmaceutical intellectual property. 2. Scientific Evaluation Stack: Utilizes over 50 custom-tuned models to conduct in-depth in silico simulations, assessing factors such as binding affinity, toxicity, pharmacokinetics (ADME/PK), immunogenicity, and mechanistic fit. 3. Specialist Human Review: Engages PhD-level experts to validate the scientific viability of each asset, ensuring thorough evaluation of biology, risks, and translatability. 4. Market Insight Agent: Analyzes market factors, including unmet medical needs, competitive landscape, intellectual property positioning, reimbursement signals, and financial projections, to prioritize assets with the highest potential. 5. Operational Risk Agent: Conducts digital twin simulations to assess execution risks before clinical trials commence, evaluating aspects like contract research organization (CRO) stability, manufacturing complexities, site readiness, and potential real-world disruptions. 6. Probability of Success Model: Employs a proprietary model to predict the likelihood of success, aggregating outputs from all agents and benchmarking against historical data to inform go/no-go decisions. 7. Final Human Review: Convenes a roundtable of key opinion leaders (KOLs) in scientific, regulatory, commercial, and clinical domains to align on risk, timing, and exit strategies before finalizing decisions. Primary Value and User Solutions: Convexia addresses the inefficiencies in traditional drug development by significantly reducing the time and resources required to identify and evaluate promising drug assets. By combining AI-driven analysis with expert human oversight, the platform enhances the accuracy and speed of drug discovery, enabling pharmaceutical companies, biotech firms, and investors to uncover and develop therapeutics more effectively. This approach not only accelerates the path to market for new drugs but also increases the likelihood of success by providing comprehensive evaluations and risk assessments at each stage of development.

Fund Subscription is a core product within the Anduin Transactions ecosystem, built to automate the digital investor onboarding process while preserving the complexity of modern fund structures through e-subscription documents and auto-fill forms. It replaces manual subscription processes with a streamlined experience that helps firms onboard investors faster with greater accuracy. The system relies on intelligent form digitization, pre-fill and autofill data reuse, and built-in KYC/AML compliance tracking. It uses conditional logic to tailor each investor's experience based on their type, jurisdiction, and prior responses, automatically surfacing relevant fields, generating required checklists, and routing collaboration directly on the form. The product helps fund managers close subscriptions faster across diverse investor types, fund structures, and geographies. Key Features: - Automated Digital Subscriptions: Replace manual paperwork with digital subscription flows, reducing administrative workload. - Conditional Logic & Guided Forms: Display only relevant fields and disclosures based on investor responses, minimizing errors and shortening review cycles. - Complex Fund Structure Support: Handle private capital structures including SPVs, feeder funds, funds-of-funds, and other vehicles with form logic that adapts to each investment’s legal and structural requirements without manual reconfiguration. - Built-In Compliance Workflows: Integrated AML/KYC checklists, data validation, and standardized processes support advanced e-signatures (AES, QES) and compliance across more than 30 jurisdictions. - Full Document Lifecycle Coverage: Digitize and manage the complete range of investor documents beyond subscription forms, including W-9s, W-8s, transfer documents, voting forms, and questionnaires. - Centralized Real-time Dashboards: Provide full visibility into investor progress, outstanding items, and overall subscription status, giving GPs greater control during fund closes. - In-Thread Comments & Issue Resolution: Comment directly on form fields to flag issues, request clarifications, and collaborate in context, with all communication logged. - Reusable Investor Data & Profiles: Securely store investor documentation for reuse across future subscriptions, helping GPs accelerate subsequent fund raises and improve LP experience over time. - Fully White-Labeled Experience: Deliver a branded onboarding experience that reflects each fund’s identity while meeting institutional investor expectations. - CRM Integration: Send subscription invitations and sync completed investor data directly with DealCloud, Affinity, and Salesforce, keeping CRM records current without manual re-entry.